SCHEMBL15906192

SCHEMBL15906192

COc1ccc(Cc2ccc(C)cc2)c(F)c1-c1cccc(C(C)=O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 2/20 0.44
CTSA P10619 3/20 0.42
HTT P42858 1/20 0.40
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
BRD4 O60885 1/20 0.39
BRD2 P25440 1/20 0.39
CREBBP Q92793 1/20 0.39
ALDH1A1 P00352 5/20 0.38
GAA P10253 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
CNR2 P34972 1/20 0.37
SYK P43405 1/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PKM P14618 1/20 0.37
FFAR1 O14842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3467069 0.90 ALDH1A1 (0.38) MAOBCTSAMEN1KMT2AALDH1A1
Hydrochloric Acid SCHEMBL3796887 0.90 SYK (0.41) MAOBCTSAMEN1KMT2AALDH1A1
SCHEMBL3467033 0.90 MRGPRX4 (0.45) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL3796531 0.89 ERN1 (0.43) MEN1KMT2AALDH1A1GAAKDM4E
SCHEMBL15906194 0.89 MAOB (0.45) MAOBMEN1KMT2ABRD4BRD2
SCHEMBL7916951 0.89 ALDH1A1 (0.42) MAOBCTSAMEN1KMT2AALDH1A1
SCHEMBL3466244 0.89 ERN1 (0.43) MEN1KMT2ACREBBPALDH1A1GAA
SCHEMBL8024453 0.89 ALDH1A1 (0.43) CTSAMEN1KMT2AALDH1A1GAA
Hydrochloric Acid SCHEMBL10318481 0.89 ALDH1A1 (0.42) CTSAMEN1KMT2AALDH1A1GAA
SCHEMBL8067401 0.89 ALDH1A1 (0.42) CTSAMEN1KMT2AALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140301999-A1 BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS DECODE GENETICS EHF (IS) 2014-10-09 US disclosed
US-8791267-B2 Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders DECODE GENETICS EHF (IS) 2014-07-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140301999-A1 BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS PDE4A, PDE4B, PDE3B MAOB 116/4885CTSA 3286/4885HTT 3498/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.